266 related articles for article (PubMed ID: 16151289)
1. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
[TBL] [Abstract][Full Text] [Related]
2. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds.
Ulkür E; Oncul O; Karagoz H; Yeniz E; Celiköz B
Burns; 2005 Nov; 31(7):874-7. PubMed ID: 16011879
[TBL] [Abstract][Full Text] [Related]
3. Effects of three different topical antibacterial dressings on Acinetobacter baumannii-contaminated full-thickness burns in rats.
Uygur F; Oncül O; Evinç R; Diktas H; Acar A; Ulkür E
Burns; 2009 Mar; 35(2):270-3. PubMed ID: 18789593
[TBL] [Abstract][Full Text] [Related]
4. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds.
Acar A; Uygur F; Diktaş H; Evinç R; Ulkür E; Oncül O; Görenek L
Burns; 2011 Aug; 37(5):882-5. PubMed ID: 21354707
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats.
Yabanoglu H; Basaran O; Aydogan C; Azap OK; Karakayali F; Moray G
Int Surg; 2013; 98(4):416-23. PubMed ID: 24229034
[TBL] [Abstract][Full Text] [Related]
7. Use of Acticoat dressings in burns: what is the evidence?
Khundkar R; Malic C; Burge T
Burns; 2010 Sep; 36(6):751-8. PubMed ID: 20346592
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful?
Varas RP; O'Keeffe T; Namias N; Pizano LR; Quintana OD; Herrero Tellachea M; Rashid Q; Ward CG
J Burn Care Rehabil; 2005; 26(4):344-7. PubMed ID: 16006842
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Controlled Study of Silver-Based Burns Dressing in a Pediatric Emergency Department.
Brown M; Dalziel SR; Herd E; Johnson K; Wong She R; Shepherd M
J Burn Care Res; 2016; 37(4):e340-7. PubMed ID: 26171678
[TBL] [Abstract][Full Text] [Related]
10. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits.
Fong J; Wood F; Fowler B
Burns; 2005 Aug; 31(5):562-7. PubMed ID: 15993301
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.
Huang Y; Li X; Liao Z; Zhang G; Liu Q; Tang J; Peng Y; Liu X; Luo Q
Burns; 2007 Mar; 33(2):161-6. PubMed ID: 17175106
[TBL] [Abstract][Full Text] [Related]
13. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study.
Silver GM; Robertson SW; Halerz MM; Conrad P; Supple KG; Gamelli RL
J Burn Care Res; 2007; 28(5):715-9. PubMed ID: 17667837
[TBL] [Abstract][Full Text] [Related]
14. Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound.
Snelling CF; Roberts FJ; Germann E; Gillespie K; Coderre S; Henry D
Burns Incl Therm Inj; 1988 Apr; 14(2):91-100. PubMed ID: 3134114
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the antibacterial effect of silver sulfadiazine 1%, mupirocin 2%, Acticoat and octenidine dihydrochloride in a full-thickness rat burn model contaminated with multi drug resistant Acinetobacter baumannii.
Selçuk CT; Durgun M; Ozalp B; Tekin A; Tekin R; Akçay C; Alabalık U
Burns; 2012 Dec; 38(8):1204-9. PubMed ID: 22688192
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of three silver dressings in an infected animal model.
Heggers J; Goodheart RE; Washington J; McCoy L; Carino E; Dang T; Edgar P; Maness C; Chinkes D
J Burn Care Rehabil; 2005; 26(1):53-6. PubMed ID: 15640735
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 1% silver sulfadiazine with and without 1% chlorhexidine digluconate for topical antibacterial effect in the burnt infected rat.
Snelling CF; Roberts FJ
J Burn Care Rehabil; 1988; 9(1):35-40. PubMed ID: 3128553
[TBL] [Abstract][Full Text] [Related]
18. [Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds].
Li XL; Huang YS; Peng YZ; Liao ZJ; Zhang GA; Liu Q; Tang J; Liu XS; Luo QZ
Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):15-8. PubMed ID: 16680954
[TBL] [Abstract][Full Text] [Related]
19. Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds.
Gray JH; Henry DA; Forbes M; Germann E; Roberts FJ; Snelling CF
Burns; 1991 Feb; 17(1):37-40. PubMed ID: 2031672
[TBL] [Abstract][Full Text] [Related]
20. Comparison of silver sulfadiazine 1% with chlorhexidine digluconate 0.2% to silver sulfadiazine 1% alone in the prophylactic topical antibacterial treatment of burns.
Snelling CF; Inman RJ; Germann E; Boyle JC; Foley B; Kester DA; Fitzpatrick DJ; Warren RJ; Courtemanche AD
J Burn Care Rehabil; 1991; 12(1):13-8. PubMed ID: 2022674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
